To the Editor:
We read the article titled “HMOX1 promoter microsatellite polymorphism is not associated with high altitude pulmonary edema in Han Chinese” by Cao et al with profound interest.
1The authors of this study have concluded that the microsatellite polymorphism in the HMOX1 gene promoter is not associated with high altitude (HA) pulmonary edema (HAPE) in Han Chinese. There has been a worldwide shift in focus among the scientific community toward research involving the proteomics and genomics aspects of this disease process. This is also evident in the present study, but the presentation of the physiologic/clinical aspects of the data appears to have taken a backseat.
- Cao X.
- Ma L.
- Ma S.
- Xu J.
- Ge R.
HMOX1 promoter microsatellite polymorphism is not associated with high altitude pulmonary edema in Han Chinese.
Wilderness Environ Med. 2017; 28: 17-22
We would like to seek more information regarding the status of the non-HAPE lowland participants in terms of the time spent at HA before their clinical examination was done and blood samples collected. Hematological parameters like hemoglobin level are definitely affected by the duration and quantum of hypoxia exposure in all individuals at HA.
2Elaboration on this aspect would enable better understanding of the results of the comparison of the 2 groups. Similarly, a word on the average time for presentation of HAPE symptoms in patients after entry in HA before they were hospitalized could have elucidated their clinical presentation further. It would also be interesting to know the duration and details of HAPE treatment (oxygen/nifedipine) provided to these patients and the timing of clinical examination measurements in the hospital. If it was not done at the time of hospitalization, then clarification on cessation of treatment before the examination was carried out would be remarkable. It is evident that from the mean resting heart rate (118±17 beats·min−1) of HAPE participants (n=83) that they had a moderate grade of HAPE.
- West J.B.
The physiologic basis of high-altitude diseases.
Ann Intern Med. 2004; 141: 789-800
3Especially in the background of the very low blood oxygen level of HAPE participants (54±19%), additional information on respiratory rate of these participants would complete their clinical profile.
- Schoene R.B.
- Swenson E.R.
- Hultgren H.N.
High altitude pulmonary edema.
in: Hornbein T.F. Schoene R.B. High Altitude: An Exploration of Human Adaptation. Mercel Dekker, New York2001: 777-814
- HMOX1 promoter microsatellite polymorphism is not associated with high altitude pulmonary edema in Han Chinese.Wilderness Environ Med. 2017; 28: 17-22
- The physiologic basis of high-altitude diseases.Ann Intern Med. 2004; 141: 789-800
- High altitude pulmonary edema.in: Hornbein T.F. Schoene R.B. High Altitude: An Exploration of Human Adaptation. Mercel Dekker, New York2001: 777-814
Published online: February 02, 2018
All rights reserved.